Owens & Minor (NYSE:OMI) Releases FY25 Earnings Guidance

Owens & Minor (NYSE:OMI - Get Free Report) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share guidance of $1.60-1.85 for the period, compared to the consensus earnings per share estimate of $1.79. The company issued revenue guidance of $10.85-11.15, compared to the consensus revenue estimate of $10.97 billion. Owens & Minor also updated its FY 2025 guidance to 1.600-1.850 EPS.

Owens & Minor Trading Up 4.7 %

Shares of Owens & Minor stock traded up $0.44 during trading on Tuesday, hitting $9.76. 4,000,581 shares of the company were exchanged, compared to its average volume of 1,716,829. The firm has a market capitalization of $752.66 million, a P/E ratio of -15.02, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. The firm's fifty day moving average price is $11.44 and its 200 day moving average price is $13.18. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor has a 1-year low of $6.07 and a 1-year high of $28.35.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.53 by $0.02. The firm had revenue of $2.70 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business's quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.69 earnings per share. As a group, sell-side analysts expect that Owens & Minor will post 1.51 earnings per share for the current fiscal year.

Remove Ads

Owens & Minor declared that its board has authorized a stock buyback program on Friday, February 28th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 13.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

OMI has been the subject of several recent analyst reports. Barclays lowered their price target on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th. Robert W. Baird raised their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a report on Monday. UBS Group cut their price target on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research note on Thursday, February 13th. Finally, Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $15.08.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.